Clinical trial
The DISTAL-2 Study: Docetaxel Alone or in Combination in Second-line Treatment…
NCT00345059 · National Cancer Institute, Naples, Other · Terminated
Key facts
| NCT number | NCT00345059 |
|---|---|
| Title | The DISTAL-2 Study: Docetaxel Alone or in Combination in Second-line Treatment of Advanced Non Small-Cell Lung Cancer |
| Official title | Single Agent Chemotherapy With Weekly Docetaxel vs Combination Chemotherapy in Second-line Treatment of Advanced Non Small Cell Lung Cancer |
| Acronym | DISTAL-2 |
| Lead sponsor | National Cancer Institute, Naples, Other |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Advanced Non-Small Cell Lung Cancer |
| Intervention type | Drug |
| Interventions | docetaxel, vinorelbine, gemcitabine, capecitabine |
| Enrollment | 84 |
| Start date | May 1, 2005 |
| Primary completion | May 1, 2008 |
| Completion | May 1, 2008 |
| First posted | Jun 27, 2006 |
| Last update posted | Jan 14, 2016 |
| Countries | Italy |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: